ZBH

Zimmer Biomet Holdings, Inc.

HealthcareMedical DevicesNASDAQ

$82.33

-$2.88 (-3.49%)today

Conviction

5/ 10

Fair Value$103

Upside+25.11%

Signal12.55

Market Cap$17.9B

52W Range$84.59–$108.29

Next EarningsMay 4

Conviction History

Conviction Changes

No conviction changes recorded

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 3,000 runs · 99% valid

Fair Value$193.37

Current Price$93.30

Upside / Down+107.3%

P(Undervalued)100.0%

P(20%+ Up)98.8%

P(15%+ Down)0.0%

Fair Value Distribution — percentile bands

100.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-5.9%/yr

±3.1% · revenue growth to justify current price

FCF-Based Reverse DCF

-3.3%/yr

±3.0% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

Zimmer Biomet orthopedic implants; procedure volume recovery; Rosa robotics competitive.

Bear Case

Pricing pressure from hospital systems; robotics competition from Stryker/JNJ; supply chain.

Updated Apr 7

Research Feed

sec_10kMar 3

Conviction: unchanged

ZBH 2025 10-K: Margin Compression Amid Growth Deceleration

ZBH facing margin compression (earnings -22% vs revenue +7.2%) driven by one-time charges, tariffs, and structural reimbursement headwinds. US sales force transformation creates near-term disruption r...